Catamaran Resort3999 Mission BlvdSan Diego, CA 92109United States,

San Diego,

CA ,

US,

ZIP: 92109

Phone:

Description

GTCbio conferences aim to facilitate transformational platforms that would have a significant impact on scientific research, drug development and healthcare. Identifying and validating new targets is a critical starting point and often times a daunting inflection point in drug development. While there is continuous innovation and invention of new assays and screening technologies, it is important to understand how these technologies will help with new and existing targets. Protein Kinases have long been an important target in several diseases and we will discuss new developments in this area at our 2021 Enzymes in Drug Discovery Summit. We will also focus on advances in Ubiquitin and Protease targeted therapies.

Please join us to be part of an exciting platform at the Enzymes in Drug Discovery Summit, which will take place February 22-23, 2021 in San Diego, CA.

This summit will feature the following four targeted areas:

Protein Kinases in Drug Discovery

• Novel Approaches, Tools and Technologies in Kinase Drug Discovery
• Kinome Selectivity & Clinical Translation

Ubiquitin Research & Drug Discovery

• Novel Drug Targets in the Ubiquitin System
• Advances in Ubiquitin-like Modifications

Epigenetic Enzymes in Drug Discovery

• Epigenetic Modification &Transcriptional Regulation
• Novel Therapeutic Targets &Translational Studies

Protease Inhibitors in Drug Discovery

• Chemistry and Drug Design of Protease Inhibitors
• Protease Inhibitors in Translational Research

In addition to scientific presentations, dedicated networking sessions will allow you to connect and form new relationships with colleagues from both the private and public sector.

AGENDA

Day 1 – Thursday, February 22, 2021
Registration and Breakfast
Opening Keynote Session – Historical Perspective and State of the Science/Industry
Morning Networking Break
Two Parallel Conferences – click the conference title for a detailed agenda
Protein Kinases Ubiquitin Research
Novel Approaches, Tools and Technologies in Kinase Drug Discovery Novel Drug Targets in the Ubiquitin System
Sponsored Lunch Workshop
Kinome Selectivity and Clinical Tranlsation Advances in Ubiquitin-like Modifications
Afternoon Networking Break
Round Table Discussions
Sponsored Reception and Poster Session

Day 2 – Friday, February 23, 2021
Breakfast with Mentors from Academia and Industry
Two Parallel Conferences – click the conference title for a detailed agenda
Epigenetic Enzymes Protease Inhibitors
Epigenetic Modification and Transcriptional Regulation Chemistry and Drug Design or Protease Inhibitors
Morning Networking Break
Novel Therapeutic Targets and Translational Studies Protease Inhibitors in Translational Research
Lunch provided by GTCbio
Award Ceremony and Closing Keynote Session – Predictions for the Future
Conference Closes

 

Matthew Bogyo 
Professor, Department of Pathology
Stanford University


Jack Taunton 
Professor, Cellular and Molecular Pharmacology, Pharmaceutical Chemistry
University of California, San Francisco

Protein Kinases in Drug Discovery
DISTINGUISHED SPEAKERS

Lars Neumann 
Assays, Biophysics & Screening
Proteros Biostructures


Gennady Verkhivker 
Professor, Computational Biosciences & Translational Medicine
Schmid College of Science & Technology, Chapman University

Ubiquitin Research and Drug Discovery
DISTINGUISHED SPEAKERS

Yuan Chen 
Professor of Molecular Medicine
Beckman Research Institute of the City of Hope


David Hewings 
Postdoctoral Research Fellow
Genentech


Matthew Petroski 
Associate Professor
Sanford-Burnham Medical Research Institute


Ryan Potts 
Associate Member, Cell & Molecular Biology Department
St. Jude Children's Research Hospital


Steven I. Reed 
Professor, Cell and Molecular Biology
The Scripps Research Institute


Domagoj Vucic 
Principal Scientist, Early Discovery Biochemistry
Genentech

Epigenetic Enzymes in Drug Discovery
DISTINGUISHED SPEAKERS

Haiching Ma 
Chief Science Officer
Reaction Biology

Protease Inhibitors in Drug Discovery
DISTINGUISHED SPEAKERS

Julio A. Camarero 
Professor, Pharmacology and Pharmaceutical Sciences
University of Southern California School of Pharmacy


Doug Johnson 
Research Fellow, Chemical Biology
Pfizer


Maurizio Pellecchia 
Professor of Biomedical Sciences
University of California, Riverside


Steven Wagner 
Associate Professor, Neuroscience
University of California San Diego

 

 

Please contact the event manager Marilyn below for the following: 
- Discounts for registering 5 or more participants.
- If you company requires a price quotation.
Event Manager Contact: marilyn.b.turner(at)nyeventslist.com
You can also contact us if you require a visa invitation letter, after ticket purchase. 
We can also provide a certificate of completion for this event if required.

NO REFUNDS ALLOWED ON REGISTRATIONS 
-----------------------------------------------------------------
This Event Listing is Promoted by
New York Media Technologies LLC in association
with GTCbio
http://www.NyEventsList.com
http://www.BostonEventsList.com
http://www.SFBayEventsList.com
-----------------------------------------------------------------
MYL170816CEV MAR170926UPT MYL171025UPD CHA171109UPT